Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cytokine synthesis inhibitor protects against polymicrobial sepsis in animal model

Oct. 6, 1997

Novel class III antiarrhythmic agents described by Merck & Co.

Oct. 6, 1997

Cypros to start phase III trial for CABG

Oct. 3, 1997

Focus on benzoyl guanidines as Na+/H+-exchange inhibitors

Oct. 2, 1997

Cytel reports encouraging results from Cylexin phase I/II trial

Oct. 2, 1997

Single- and multiple-dose clinical studies reported for SL-91.0102

Oct. 1, 1997

New treatment for ISH evaluated in humans

Oct. 1, 1997

Na+/K+-exchange inhibitors from Fujisawa

Sep. 30, 1997

Clinical pharmacokinetics and bradycardic activity of S-16257

Sep. 30, 1997

Mechanism of action revealed for Theratechnologies' Protectazem

Sep. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...